These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8123424)

  • 1. Pharmacokinetic modelling of mivacurium.
    Fisher DM; Hale V
    Br J Anaesth; 1993 Aug; 71(2):328-9. PubMed ID: 8123424
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacodynamics of mivacurium in infants.
    Meretoja OA; Taivainen T; Wirtavuori K; Olkkola KT
    Br J Anaesth; 1994 Oct; 73(4):490-3. PubMed ID: 7695717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of the benzylisoquinolinium muscle relaxants.
    Hull CJ
    Acta Anaesthesiol Scand Suppl; 1995; 106():13-7. PubMed ID: 8533537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The train-of-four count and recovery from mivacurium.
    Kopman AF
    Anesth Analg; 1999 Aug; 89(2):536. PubMed ID: 10439789
    [No Abstract]   [Full Text] [Related]  

  • 5. High-performance liquid chromatographic assays with fluorometric detection for mivacurium isomers and their metabolites in human plasma.
    Lacroix M; Tu TM; Donati F; Varin F
    J Chromatogr B Biomed Appl; 1995 Jan; 663(2):297-307. PubMed ID: 7735477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid method for the quantitation of mivacurium isomers in human and dog plasma by using liquid chromatography with fluorescence detection: application to pharmacokinetic studies.
    Lugo SI; Eddington ND
    J Pharm Biomed Anal; 1996 Apr; 14(6):675-83. PubMed ID: 8807542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The identification of mivacurium and metabolites in biological samples.
    Montgomery MA; LeBeau MA; Miller ML; Jufer RA
    J Anal Toxicol; 2005 Oct; 29(7):637-42. PubMed ID: 16419393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic variables of mivacurium chloride after intravenous administration in dogs.
    Smith LJ; Schwark WS; Cook DR; Moon PF; Looney AL
    Am J Vet Res; 1999 Sep; 60(9):1051-4. PubMed ID: 10490070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral link model as an alternative for pharmacokinetic-pharmacodynamic modeling of drugs having a very short elimination half-life.
    Laurin J; Donati F; Nekka F; Varin F
    J Pharmacokinet Pharmacodyn; 2001 Feb; 28(1):7-25. PubMed ID: 11253615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onset of action of mivacurium chloride. A comparison of neuromuscular blockade monitoring at the adductor pollicis and the orbicularis oculi.
    Sayson SC; Mongan PD
    Anesthesiology; 1994 Jul; 81(1):35-42. PubMed ID: 8042808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged neuromuscular block after mivacurium in a patient with end-stage renal disease.
    Mangar D; Kirchhoff GT; Rose PL; Castellano FC
    Anesth Analg; 1993 Apr; 76(4):866-7. PubMed ID: 8466030
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of mivacurium isomers and their metabolites in healthy volunteers after intravenous bolus administration.
    Lacroix M; Donati F; Varin F
    Anesthesiology; 1997 Feb; 86(2):322-30. PubMed ID: 9054251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of halothane, enflurane and isoflurane on the pharmacodynamics of mivacurium in children. G. Neidhart, C. Pabelick, I. Kuhn, M. Leuwer, J. Vetterman, AINS 31:293-297, 1996].
    Cramer R
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Jun; 34(6):384. PubMed ID: 10429781
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mivacurium. A non-depolarizing neuromuscular blocking agent with short-lasting effect].
    Ostergaard D; Mogensen JV
    Ugeskr Laeger; 1998 Mar; 160(14):2126-30. PubMed ID: 9604687
    [No Abstract]   [Full Text] [Related]  

  • 15. [The clinical pharmacology of mivacurium].
    Diefenbach C; Mellinghoff H
    Anaesthesist; 1997 May; 46(5):385-8. PubMed ID: 9245207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between mivacurium and pancuronium: impact of the order of administration.
    Motamed C; Kirov K; Combes X; Feiss P; Duvaldestin P
    Eur J Clin Pharmacol; 2005 May; 61(3):175-7. PubMed ID: 15824913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prolonged neuromuscular block induced by mivacurium].
    Bensaid A; Miloudi Y; El Harrar N
    Ann Fr Anesth Reanim; 2006 Apr; 25(4):462-3. PubMed ID: 16377125
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of hepatic cirrhosis on the pharmacodynamics and pharmacokinetics of mivacurium in humans.
    Levy G
    Pharm Res; 1994 May; 11(5):772-3. PubMed ID: 8058651
    [No Abstract]   [Full Text] [Related]  

  • 19. Onset and duration of mivacurium-induced neuromuscular blockade in children with Charcot-Marie-Tooth disease. A case series with five children.
    Schmitt HJ; Wick S; Münster T
    Paediatr Anaesth; 2006 Feb; 16(2):182-7. PubMed ID: 16430417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prolonged neuromuscular blockade caused by mivacurium in a pediatric patient].
    Fernández-Rosado B; Vázquez-Fidalgo A; Pensado-Castiñeiras A; Figueira-Moure A; Rama-Maceiras P; Pose-Cambeiro P
    Rev Esp Anestesiol Reanim; 1999 Feb; 46(2):92. PubMed ID: 10100446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.